FARMAK, a. s. is a significant European pharmaceutical and chemical company focused on development, manufacture and marketing of three product groups:
active pharmaceutical ingredients
chemical intermediates and specialities
disinfectants
From a long-term point of view, the key role for the company performance is manufacture and sales of active pharmaceutical ingredients. The company is a significant exporter: the share of exports in takings is almost 90 %. Products of FARMAK, a. s. are exported to more than 40 countries of the whole world. USA, EU countries, Japan and Switzerland belong to the most important export territories.
FARMAK, a. s. has at disposal production facilities with reactor capacity of about 215 m3. Multipurpose facilities are continually upgraded and they enable flexibility in custom manufacturings from kilogram to ton volumes of products.
A part of the company strategy is integrated policy of quality and environment. The system of quality assurance complies with current requirements of cGMP. Production facilities are regularly inspected by The State Institute for Drug (SUKL), by the American Food and Drug Administration (FDA) and by customer audits.
FARMAK, a.s. has an introduced and certified integrated system of the quality control and environmental protection as per
?SN EN ISO 9001:2001 and ?SN EN ISO 14001:2005 standards.
FARMAK, a. s. pays full attention to environmental and safety problems and keeps the Responsible Care program in chemistry.
At present FARMAK, a. s. employs 259 workers that have to meet demanding requirements for qualification and education.